Skip to main content
. Author manuscript; available in PMC: 2012 Mar 29.
Published in final edited form as: Circulation. 2011 Mar 14;123(12):1297–1305. doi: 10.1161/CIRCULATIONAHA.110.981720

Table 1.

Summary of the rats used in this study.

Study Strain Treatment Number Duration (weeks)
Cardiac delivery SHR AAV9-Luc 2 3
Toxicology SHR Untreated 3 3
SHR AAV9-Luc 3 3
SHR AAV9-BNP 3 3
Pharmacokinetics/dynamics SHR Untreated 8 40
SHR AAV9-BNP 8 40
Non-cardiac delivery SHR Untreated 5 8
SHR AAV2-BNP 5 8
SHR AAV9-BNP 3 8
Normotensive rat study Wistar AAV9-GFP 6 4
Wistar AAV9-BNP 6 4

SHR, spontaneously hypertensive rats; Luc, luciferase; GFP, green fluorescent protein.